Cerebral oedema and increased intracranial pressure in chronic liver disease

被引:130
作者
Donovan, JP [1 ]
Schafer, DF
Shaw, BW
Sorrell, MF
机构
[1] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Surg, Omaha, NE 68198 USA
关键词
D O I
10.1016/S0140-6736(97)07373-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cerebral oedema is a cause of morbidity and mortality in fulminant hepatic failure but has not been well documented as a complication of chronic liver diseases. We report here the development of cerebral oedema and increased intracranial pressure in 12 patients with chronic liver disease. Methods Between July 1, 1987, and Dec 31, 1993, we studied 12 patients aged 29-67 years with end-stage chronic liver disease. All the patients had cirrhosis. portal hypertension, hypoprothrombinaemia, hepatic encephalopathy, and decreased serum concentrations of albumin (<25 g/L). During the study, the patients developed signs of increased intracranial pressure and had documented intracranial hypertension, cerebral oedema, or both. Intracranial hypertension was suspected on physical examination and confirmed by epidural catheters. We detected cerebral oedema by computed axial tomography of the head and necropsy of the brain when possible. Findings All the patients had intracranial hypertension and cerebral oedema. Two patients had successful treatment of cerebral hypertension with improvement of intracranial pressure such that orthotopic liver transplantation was undertaken. Both patients became neurologically normal after transplantation. Eight patients had only a transient reponse to treatment and died of cerebral oedema before a transplant could be done. Interpretation Cerebral oedema and increased intracranial pressure can occur in chronic liver disease and presents as neurological deterioration. Treatment guided by monitoring of intracranial pressure can lead to the reversal of intracranial hypertension, but in most patients cerebral oedema contributes to death or places them at too high a risk for liver transplantation.
引用
收藏
页码:719 / 721
页数:3
相关论文
共 9 条
[1]   CONTROLLED TRIAL OF DEXAMETHASONE AND MANNITOL FOR THE CEREBRAL EDEMA OF FULMINANT HEPATIC-FAILURE [J].
CANALESE, J ;
GIMSON, AES ;
DAVIS, C ;
MELLON, PJ ;
DAVIS, M ;
WILLIAMS, R .
GUT, 1982, 23 (07) :625-629
[2]   REVERSIBLE DECEREBRATE AND DECORTICATE POSTURES IN HEPATIC COMA [J].
CONOMY, JP ;
SWASH, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (16) :876-+
[3]  
JABBOUR N, 1994, J OKLA STATE MED ASS, V84, P501
[4]   INTRACRANIAL-PRESSURE MONITORING AND LIVER-TRANSPLANTATION FOR FULMINANT HEPATIC-FAILURE [J].
LIDOFSKY, SD ;
BASS, NM ;
PRAGER, MC ;
WASHINGTON, DE ;
READ, AE ;
WRIGHT, TL ;
ASCHER, NL ;
ROBERTS, JP ;
SCHARSCHMIDT, BF ;
LAKE, JR .
HEPATOLOGY, 1992, 16 (01) :1-7
[5]  
Plum F, 1980, DIAGNOSIS STUPOR COM, P177
[6]  
Schafer DF, 1990, HEPATOLOGY, P447
[7]  
SCHAFER DF, 1990, CURRENT THERAPY GAST, P451
[8]   EFFECTS OF VASOPRESSOR AGENTS AND EPOPROSTENOL ON SYSTEMIC HEMODYNAMICS AND OXYGEN-TRANSPORT IN FULMINANT HEPATIC-FAILURE [J].
WENDON, JA ;
HARRISON, PM ;
KEAYS, R ;
GIMSON, AE ;
ALEXANDER, GJM ;
WILLIAMS, R .
HEPATOLOGY, 1992, 15 (06) :1067-1071
[9]   The use of hyperventilation and its impact on cerebral ischemia in the treatment of traumatic brain injury [J].
Yundt, KD ;
Diringer, MN .
CRITICAL CARE CLINICS, 1997, 13 (01) :163-+